Manzo Pharmaceuticals (MNZO)
OTHER OTC:MNZO
US Market

Manzo Pharmaceuticals (MNZO) Income Statement

0 Followers

Manzo Pharmaceuticals Income Statement

Last quarter (Q ), Manzo Pharmaceuticals's total revenue was $0.00, a decrease of ― from previous quarter. In Q, Manzo Pharmaceuticals's net income was $-1.23M. See Manzo Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 04Dec 03
Total Revenue
-$ 3.07M$ 3.00M
Cost of Revenue
$ 27.77K$ 3.05M$ 2.25M
Gross Profit
$ -27.77K$ 20.97K$ 755.89K
Operating Expense
$ 2.91M$ 3.22M$ 4.00M
Operating Income
$ -2.94M$ -3.20M$ -3.25M
Net Non Operating Interest Income Expense
---
Other Income Expense
$ -18.34K-$ 11.44K
Pretax Income
---
Tax Provision
---
Earnings From Equity Interest Net Of Tax
---
Net Income Common Stockholders
$ -3.28M$ -4.15M$ -3.95M
Basic EPS
$ -0.80$ -1.20$ -1.20
Diluted EPS
$ -0.80$ -1.20$ -1.20
Basic Average Shares
$ 12.29M$ 3.46M$ 3.22M
Diluted Average Shares
$ 12.29M$ 3.46M$ 3.22M
Dividend Per Share
---
Total Operating Income As Reported
---
Reported Normalized Basic E P S
---
Reported Normalized Diluted E P S
---
Rent Expense Supplemental
---
Total Expenses
$ 2.94M$ 6.27M$ 6.25M
Interest Expense
---
Net Income From Continuing And Discontinued Operation
$ -3.28M$ -4.15M$ -3.95M
Normalized Income
$ -3.25M$ -4.15M$ -3.96M
EBIT
$ -2.94M$ -3.20M$ -3.25M
EBITDA
$ -2.87M$ -2.85M$ -2.30M
Currency in USD

Manzo Pharmaceuticals Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis